Lantern Pharma Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
Find out what a historical investment in Lantern Pharma Inc would be worth today using our LTRN stock calculator.
$34.51M
-
0.00%
1.24K
$3.33
$3.08
$0.00
$6.12
$2.55
Ready to start your investing journey with Stake?
Open an accountLTRN FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LTRN
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LTRN
on Stake
Buy LTRN from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of LTRN from only US$10 with fractional shares
